Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Vaccine|July 11, 2006
The adjuvant potential of synthetic alkylglycerolsReinaldo Acevedo, Danay Gil, Judith del Campo, et al.Expert Review of Vaccines|December 20, 2008
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?Jamie F S Mann, Reinaldo Acevedo, Judith Del Campo, et al.Vaccine|July 11, 2006
Strategy for determination of an efficient Cochleate particle sizeDanay Gil, Gustavo Bracho, Caridad Zayas, et al.Biologicals : Journal of the International Association of Biological Standardization|August 26, 2003
Validation of colorimetric assay to detect complement-mediated antibody-dependent bactericidal activity against serogroups B and C Neisseria meningitidisTamara Rodríguez, Miriam Lastre, Bárbara Cedré, et al.Vaccine|December 1, 2009
Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in miceJudith Del Campo, Madelene Lindqvist, Maribel Cuello, et al.Clinical and Diagnostic Laboratory Immunology|January 5, 2002
Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assayTamara Rodríguez, Miriam Lastre, Barbara Cedré, et al.Methods (San Diego, Calif.)|May 5, 2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responsesJudith Del Campo, Caridad Zayas, Belkis Romeu, et al.Vaccine|July 11, 2006
Proteoliposome derived cochleate as novel adjuvantGustavo Bracho, Miriam Lastre, Judith del Campo, et al.Vaccine|July 11, 2006
Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvantsJudith del Campo, Miriam Lastre, Gustavo Bracho, et al.Vaccine|July 11, 2006
Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoidJulio A Balboa, Maribel Cuello, Osmir Cabrera, et al.Pageof 3